BPC-157 is an investigational synthetic peptide sold online in capsules, injectable vials, sprays, and “research use only” products. It is not FDA-approved for any medical use 1, human evidence is limited, and online product quality can vary 2. Chia does not currently offer BPC-157.
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you buy BPC-157 peptide online?
Yes, BPC-157 products are easy to find online, but “for sale” does not mean FDA-approved, clinically proven, sterile, or appropriate for you. FDA’s public drug database does not list an approved BPC-157 drug product, and products marketed with disease-treatment claims can raise safety and labeling concerns 1.
What people usually mean by “for sale online”
Online shoppers may see BPC-157 acetate sold as capsules, injectable vials, nasal sprays, topical products, or powders. These products can appear on supplement sites, peptide sites, research-chemical sites, and clinic-style pages. The route, source, and oversight can differ a lot.
Why some products are labeled “research use only”
“Research use only” usually means the seller is not presenting the product as an approved medication for patient treatment. That label does not prove the product is safe, sterile, accurately dosed, or legal for personal medical use. FDA warns that buying health products from online sources can expose patients to products with unsafe ingredients, wrong strength, or poor quality controls 2.
Why supplement, research chemical, and prescription claims are not the same
A dietary supplement claim is not the same as an FDA-approved drug indication. A research-chemical label is not the same as a prescription. A prescription path, when appropriate, should include clinician review, identifiable pharmacy or manufacturer information, and a way to ask for help if side effects occur.
What is BPC-157?
BPC-157 stands for Body Protection Compound-157. It is often described as a synthetic pentadecapeptide, meaning a lab-made peptide made of 15 amino acids, and it is structurally related to a peptide sequence studied from gastric juice proteins 3.
You may also see it called BPC-157 acetate. It has no FDA-approved BPC-157 brand name and no FDA-approved generic INN for BPC-157. Its practical drug class is best described as an investigational peptide, not an approved medication class.
Common online forms include capsules, injectable vials, nasal sprays, topical gels, and creams. These forms should not be assumed to act the same way. Absorption, sterility needs, contamination risk, and labeling can differ by route.
What is BPC-157 peptide good for, according to current evidence?
The honest answer is that BPC-157 has been investigated mostly in animal and cell models for tissue repair, gastrointestinal injury, blood-flow signaling, and inflammation. Those findings are interesting, but they do not prove that BPC-157 heals injuries or improves gut health in humans, and BPC-157 is not FDA-approved for any medical use.
Tendon, ligament, and muscle recovery claims
In rat models, BPC-157 has been studied in Achilles tendon injury and other soft-tissue injury settings, with researchers reporting changes in healing-related outcomes 4. Cell research has also explored tendon fibroblast activity, a process involved in tendon repair biology 5. These are preclinical signals, not proof of human tendon or ligament healing, and BPC-157 is not FDA-approved for these uses.
The safety side matters just as much. Because BPC-157 does not have an FDA-approved label, there is no FDA-reviewed dosing schedule, contraindication list, adverse-event rate, or human outcomes dataset for patients to rely on 1.
Gut and stomach-lining claims
BPC-157 has been studied in animal models of gastrointestinal injury, including stomach and intestinal injury models 3. These studies help scientists ask better questions about gastrointestinal mucosa, but they do not show that an online BPC-157 capsule can treat reflux, ulcers, inflammatory bowel disease, or other human gut conditions, and BPC-157 is not FDA-approved for any gut-related indication.
People with abdominal pain, bleeding, weight loss, anemia, vomiting, or ongoing digestive symptoms should not use a peptide product as a substitute for medical care. Those symptoms need a clinician’s review because they can have many causes.
Inflammation and blood-flow claims
Some research has focused on nitric oxide signaling, angiogenesis, fibroblast activity, collagen organization, and inflammatory pathways 5. These mechanisms are biologically plausible, but mechanism is not the same as a proven patient benefit, and BPC-157 is not FDA-approved for inflammation or blood-flow treatment.
Any possible benefit has to be weighed against practical risks: unknown purity, strength, sterility, interactions, and the lack of strong human safety data. Individual results cannot be predicted from animal or cell findings.
Is BPC-157 FDA-approved or legally prescribed?
BPC-157 is not FDA-approved for any medical use. That means FDA has not reviewed a BPC-157 product for safety, effectiveness, dosing, manufacturing quality, or patient labeling through the standard drug-approval process 1.
Approval status matters because approved drug labels give clinicians and patients a shared source for studied uses, dosing schedules, warnings, adverse reactions, and contraindications. BPC-157 does not have that kind of FDA-reviewed label.
Compounded or research-grade peptide claims also need careful reading. A state-licensed 503A compounding pharmacy is different from a no-prescription research-chemical seller, but compounding status is not the same as FDA approval 8.
What are the risks of buying BPC-157 online?
The biggest risks are not just whether BPC-157 “works.” They are whether the product is what the label says, whether it is sterile if injected, whether the strength is accurate, and whether anyone qualified has checked if it fits your health history.
- Unknown identity, purity, or strength: online products may not match the label, especially when no independent testing is provided.
- Sterility concerns: injectable products carry added risk because contamination can enter deeper tissue or the bloodstream.
- Misleading claims: claims about healing tendon injury, ligament injury, muscle strain, gut disease, or inflammation may go beyond human evidence.
- No clinician screening: medical history, medications, pregnancy status, cancer history, immune issues, and procedure plans can all change risk.
- No follow-up plan: side effects, injection-site problems, allergic reactions, or worsening symptoms need a real care team, not just a checkout page.
- Sport rules: athletes should know that the World Anti-Doping Agency’s Prohibited List includes non-approved substances under section S0, which can include investigational substances without human therapeutic approval 9.
Sterile compounding has specific standards because contamination can harm patients. USP’s sterile compounding chapter sets requirements for facilities, training, environmental controls, and quality practices for sterile preparations 10.
How do BPC-157 capsules, injections, and other forms compare?
BPC-157 capsules and injections are not interchangeable just because they share a name. Route affects absorption, local risk, sterility needs, and the kinds of claims sellers tend to make.
| Online form | Typical online claim | Key concern | Clinician-access issue |
|---|---|---|---|
| Capsules | Gut comfort, recovery, inflammation support | Absorption and human benefit are not established; supplement-style claims may overstate evidence | Often sold without clinician review |
| Injectable vials | Tendon, ligament, muscle, or injury recovery | Sterility, contamination, reconstitution, injection technique, and strength errors | Higher need for prescription-level oversight and follow-up |
| Nasal sprays | Systemic peptide access without injections | Variable absorption and limited route-specific human evidence | Often unclear who made it and whether testing is available |
| Topical products | Localized skin or tissue support | Skin absorption and target-tissue delivery are uncertain | Claims may not match evidence for that route |
| Research-use-only powders | Laboratory research, not patient care | Not labeled for human use; identity and handling may be unclear | Usually no medical screening or care team |
This article does not give BPC-157 dosing, cycling, injection, or reconstitution instructions. For a non-FDA-approved investigational peptide, anonymous dosing advice can be unsafe because there is no FDA-reviewed label and no complete human safety framework 1.
What should you check before buying any peptide online?
Before buying any peptide online, check whether there is real medical oversight and a clear product source. A safer access path starts with a licensed clinician and an identifiable pharmacy or manufacturer, not a product page alone.
- Is there a licensed clinician evaluation before use?
- Is a prescription required when appropriate?
- Is the pharmacy, manufacturer, or compounder identifiable?
- Are sterility, potency, purity, and third-party testing documents available and current?
- Do the claims match human evidence, not just animal or cell data?
- Can you contact a care team if side effects or questions come up?
- Does the seller avoid disease-treatment claims for products that are not FDA-approved?
- If a product is injected, are sterile handling and pharmacy standards clearly addressed?
FDA’s BeSafeRx program advises patients to use caution with online drug sellers and to look for clear signs of legitimate pharmacy practice, including prescription requirements and pharmacist access 2. For compounded sterile products, pharmacy quality systems and sterility practices are especially important 10.
Peptide access at Chia: what Chia offers instead of BPC-157
Chia does not currently offer BPC-157. We do not sell, prescribe, compound, or ship BPC-157. If your goal is peptide or longevity care, our role is to offer clinician-reviewed access only to treatments in our current catalog.
Chia’s available peptide and longevity treatments include GHK-Cu cream, glutathione injection or nasal spray, NAD+ injection or nasal spray, PT-141 nasal spray, and sermorelin injection, nasal spray, or tablets. These treatments, when compounded, are not FDA-approved. We also offer protocols such as Foundation Longevity, which includes sermorelin injection, NAD+ injection, and glutathione injection.
| Chia treatment | Forms listed in Chia’s catalog | Current starting price | How access works |
|---|---|---|---|
| GHK-Cu | Cream | From $159/mo | Online health questionnaire, licensed US provider review, 503A pharmacy dispensing when appropriate |
| Glutathione | Injection, nasal spray | From $179/mo | Provider-guided treatment if prescribed; shipped to the patient’s door |
| NAD+ | Injection, nasal spray | Nasal spray from $119/mo; injection from $179/mo | Online care with provider review and patient-portal messaging |
| PT-141 | Nasal spray | From $159/mo | Prescription only when clinically appropriate |
| Sermorelin | Injection, nasal spray, tablets | From $179/mo | Provider-guided dosing and follow-up through Chia |
Treatment at Chia is 100% online: you complete a short health questionnaire, then a licensed US provider reviews it and prescribes only when clinically appropriate. Prescriptions are not guaranteed. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door; compounded medications are not FDA-approved.
Patients can start through Chia’s online eligibility quiz. Where appropriate, AI agents can also reach Chia through DoctorMCP at mcp.chia.health to help patients navigate the same clinician-reviewed access path.
Who should be especially cautious about BPC-157?
Everyone should be cautious with BPC-157, but some people need extra care. Limited human evidence means there is no strong way to predict risk for people with complex medical histories.
- People with active medical conditions or long medication lists, because interactions and disease-specific risks may be missed without clinician review.
- Pregnant or breastfeeding patients, because safety has not been established in these groups.
- People with a history of cancer, abnormal tissue growth, or unexplained masses, because BPC-157 is often discussed online in relation to angiogenesis and tissue-repair pathways.
- Athletes subject to anti-doping rules, because investigational substances without human therapeutic approval can fall under WADA’s prohibited S0 category 9.
- Anyone considering injectable products without a prescription, sterile pharmacy controls, or a care team.
If you are dealing with an injury, gut symptoms, chronic inflammation, or recovery concerns, the safer first step is a real medical evaluation. Peptides should not replace diagnosis, physical therapy, imaging when needed, or evidence-based treatment.
3-min quiz
Talk with Chia about peptide and longevity goals
Chia does not offer BPC-157. If you want to explore treatments Chia does offer, you can start with our online eligibility process. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded medications through Chia are not FDA-approved.
FAQ
BPC-157 is sold online, but it is not FDA-approved for any medical use. Whether a specific product is lawful depends on how it is made, labeled, marketed, and sold. Be careful with products that make disease-treatment or injury-healing claims without FDA approval.
No. Chia does not currently sell, prescribe, compound, or ship BPC-157. Chia’s current peptide and longevity catalog includes GHK-Cu, glutathione, NAD+, PT-141, and sermorelin in the forms listed on Chia’s product pages.
There is no FDA-approved BPC-157 prescription drug. Some clinics or sellers may discuss compounded or research-grade BPC-157, but that is not the same as an FDA-approved medication with an FDA-reviewed label.
Capsules avoid needle-related risks, but that does not prove they are safe or effective. Capsules can still have quality, purity, strength, labeling, and evidence problems. Injections add sterility and injection-technique risks.
Animal and cell studies have explored BPC-157 in tendon and soft-tissue repair models, but this does not prove it heals human tendon or ligament injuries. Human benefit and safety are not well established.
BPC-157 has been studied in animal models related to the stomach and intestines, but that does not prove safety or benefit for human gut conditions. Ongoing gut symptoms should be reviewed by a clinician.
Ask whether the peptide has human evidence for your goal, what side effects are known or unknown, whether it could interact with your medications, whether it is appropriate with your medical history, who makes it, and how to get help if side effects occur.
Chia currently offers GHK-Cu cream, glutathione injection or nasal spray, NAD+ injection or nasal spray, PT-141 nasal spray, and sermorelin injection, nasal spray, or tablets. Access requires an online health questionnaire and licensed US provider review.
References
- 1.U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs database, 2026. Retrieved August 30, 2026.
- 2.U.S. Food and Drug Administration. BeSafeRx: Know Your Online Pharmacy, 2026. Retrieved August 30, 2026.
- 3.Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 2011.
- 4.Staresinic M, Petrovic I, Novinscak T, et al. Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157. Journal of Orthopaedic Research, 2006.
- 5.Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon fibroblast outgrowth, cell survival, and migration. Journal of Applied Physiology, 2011.
- 6.U.S. Food and Drug Administration. July 23–24, 2026 Pharmacy Compounding Advisory Committee Meeting materials, 2026.
- 7.Endpoints News. FDA compounding advisers recommend six of seven nominated peptides for 503A Bulks List consideration, 2026.
- 8.U.S. Food and Drug Administration. Human Drug Compounding: Section 503A of the Federal Food, Drug, and Cosmetic Act, 2026.
- 9.World Anti-Doping Agency. The 2026 Prohibited List: International Standard, 2026.
- 10.United States Pharmacopeia. USP General Chapter <797>: Pharmaceutical Compounding—Sterile Preparations, 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
